nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—Multiple congenital abnormalities—Thalidomide—leprosy	0.118	0.118	CcSEcCtD
Cidofovir—Cholangitis—Thalidomide—leprosy	0.0327	0.0327	CcSEcCtD
Cidofovir—Creatinine low—Thalidomide—leprosy	0.0296	0.0296	CcSEcCtD
Cidofovir—Blood creatinine decreased—Thalidomide—leprosy	0.027	0.027	CcSEcCtD
Cidofovir—Nephrotic syndrome—Dapsone—leprosy	0.0229	0.0229	CcSEcCtD
Cidofovir—Hypoproteinaemia—Thalidomide—leprosy	0.0193	0.0193	CcSEcCtD
Cidofovir—Hypochromic anaemia—Thalidomide—leprosy	0.0146	0.0146	CcSEcCtD
Cidofovir—Dementia—Thalidomide—leprosy	0.0138	0.0138	CcSEcCtD
Cidofovir—Proteinuria—Dapsone—leprosy	0.0126	0.0126	CcSEcCtD
Cidofovir—Protein urine present—Dapsone—leprosy	0.0124	0.0124	CcSEcCtD
Cidofovir—Aphthous stomatitis—Thalidomide—leprosy	0.0121	0.0121	CcSEcCtD
Cidofovir—Tongue discolouration—Thalidomide—leprosy	0.0117	0.0117	CcSEcCtD
Cidofovir—Peripheral vascular disorder—Thalidomide—leprosy	0.0116	0.0116	CcSEcCtD
Cidofovir—Myasthenia—Thalidomide—leprosy	0.00901	0.00901	CcSEcCtD
Cidofovir—Oral candidiasis—Thalidomide—leprosy	0.00892	0.00892	CcSEcCtD
Cidofovir—Hypomagnesaemia—Thalidomide—leprosy	0.00892	0.00892	CcSEcCtD
Cidofovir—Nail disorder—Thalidomide—leprosy	0.00874	0.00874	CcSEcCtD
Cidofovir—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00831	0.00831	CcSEcCtD
Cidofovir—Hypercalcaemia—Thalidomide—leprosy	0.00816	0.00816	CcSEcCtD
Cidofovir—Lung disorder—Thalidomide—leprosy	0.00801	0.00801	CcSEcCtD
Cidofovir—Hepatomegaly—Thalidomide—leprosy	0.00801	0.00801	CcSEcCtD
Cidofovir—Hyperlipidaemia—Thalidomide—leprosy	0.00786	0.00786	CcSEcCtD
Cidofovir—Amblyopia—Thalidomide—leprosy	0.00734	0.00734	CcSEcCtD
Cidofovir—Skin ulcer—Thalidomide—leprosy	0.00728	0.00728	CcSEcCtD
Cidofovir—Hyperaesthesia—Thalidomide—leprosy	0.00722	0.00722	CcSEcCtD
Cidofovir—Muscular weakness—Dapsone—leprosy	0.00709	0.00709	CcSEcCtD
Cidofovir—Pancreatitis—Dapsone—leprosy	0.00681	0.00681	CcSEcCtD
Cidofovir—Proteinuria—Thalidomide—leprosy	0.00645	0.00645	CcSEcCtD
Cidofovir—Accidental injury—Thalidomide—leprosy	0.0064	0.0064	CcSEcCtD
Cidofovir—Protein urine present—Thalidomide—leprosy	0.00636	0.00636	CcSEcCtD
Cidofovir—Photosensitivity reaction—Dapsone—leprosy	0.00634	0.00634	CcSEcCtD
Cidofovir—Skin discolouration—Thalidomide—leprosy	0.00627	0.00627	CcSEcCtD
Cidofovir—Arthropathy—Thalidomide—leprosy	0.00623	0.00623	CcSEcCtD
Cidofovir—Cellulitis—Thalidomide—leprosy	0.00623	0.00623	CcSEcCtD
Cidofovir—Hypocalcaemia—Thalidomide—leprosy	0.00619	0.00619	CcSEcCtD
Cidofovir—Herpes simplex—Thalidomide—leprosy	0.00615	0.00615	CcSEcCtD
Cidofovir—Neuropathy peripheral—Dapsone—leprosy	0.00607	0.00607	CcSEcCtD
Cidofovir—Leukocytosis—Thalidomide—leprosy	0.00603	0.00603	CcSEcCtD
Cidofovir—Hearing impaired—Thalidomide—leprosy	0.00595	0.00595	CcSEcCtD
Cidofovir—Bone pain—Thalidomide—leprosy	0.00592	0.00592	CcSEcCtD
Cidofovir—Sinusitis—Dapsone—leprosy	0.00581	0.00581	CcSEcCtD
Cidofovir—Gait disturbance—Thalidomide—leprosy	0.00581	0.00581	CcSEcCtD
Cidofovir—Coordination abnormal—Thalidomide—leprosy	0.00577	0.00577	CcSEcCtD
Cidofovir—Neck pain—Thalidomide—leprosy	0.00574	0.00574	CcSEcCtD
Cidofovir—Phosphatase alkaline increased—Thalidomide—leprosy	0.00567	0.00567	CcSEcCtD
Cidofovir—Hepatocellular injury—Thalidomide—leprosy	0.00567	0.00567	CcSEcCtD
Cidofovir—Hyperkalaemia—Thalidomide—leprosy	0.00557	0.00557	CcSEcCtD
Cidofovir—Pharyngitis—Dapsone—leprosy	0.00552	0.00552	CcSEcCtD
Cidofovir—Colitis—Thalidomide—leprosy	0.00544	0.00544	CcSEcCtD
Cidofovir—Candida infection—Thalidomide—leprosy	0.00541	0.00541	CcSEcCtD
Cidofovir—Blood urea increased—Thalidomide—leprosy	0.00535	0.00535	CcSEcCtD
Cidofovir—Aplastic anaemia—Thalidomide—leprosy	0.00532	0.00532	CcSEcCtD
Cidofovir—Neuropathy—Thalidomide—leprosy	0.00532	0.00532	CcSEcCtD
Cidofovir—Dry eye—Thalidomide—leprosy	0.00523	0.00523	CcSEcCtD
Cidofovir—Cramps of lower extremities—Thalidomide—leprosy	0.00521	0.00521	CcSEcCtD
Cidofovir—Tinnitus—Dapsone—leprosy	0.00518	0.00518	CcSEcCtD
Cidofovir—Oesophagitis—Thalidomide—leprosy	0.00518	0.00518	CcSEcCtD
Cidofovir—Hypertonia—Thalidomide—leprosy	0.00497	0.00497	CcSEcCtD
Cidofovir—Sepsis—Thalidomide—leprosy	0.00492	0.00492	CcSEcCtD
Cidofovir—Lymphadenopathy—Thalidomide—leprosy	0.00482	0.00482	CcSEcCtD
Cidofovir—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00473	0.00473	CcSEcCtD
Cidofovir—Deafness—Thalidomide—leprosy	0.0046	0.0046	CcSEcCtD
Cidofovir—Eczema—Thalidomide—leprosy	0.00458	0.00458	CcSEcCtD
Cidofovir—Eye pain—Thalidomide—leprosy	0.00456	0.00456	CcSEcCtD
Cidofovir—Cardiac failure congestive—Thalidomide—leprosy	0.00454	0.00454	CcSEcCtD
Cidofovir—Injury—Thalidomide—leprosy	0.00448	0.00448	CcSEcCtD
Cidofovir—Renal failure acute—Thalidomide—leprosy	0.00446	0.00446	CcSEcCtD
Cidofovir—Amnesia—Thalidomide—leprosy	0.00438	0.00438	CcSEcCtD
Cidofovir—Dermatitis exfoliative—Thalidomide—leprosy	0.00436	0.00436	CcSEcCtD
Cidofovir—Vertigo—Dapsone—leprosy	0.00435	0.00435	CcSEcCtD
Cidofovir—Cough—Dapsone—leprosy	0.00422	0.00422	CcSEcCtD
Cidofovir—Hypoglycaemia—Thalidomide—leprosy	0.00421	0.00421	CcSEcCtD
Cidofovir—Hyponatraemia—Thalidomide—leprosy	0.00413	0.00413	CcSEcCtD
Cidofovir—Diplopia—Thalidomide—leprosy	0.00411	0.00411	CcSEcCtD
Cidofovir—Osteoarthritis—Thalidomide—leprosy	0.00411	0.00411	CcSEcCtD
Cidofovir—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00411	0.00411	CcSEcCtD
Cidofovir—Disturbance in sexual arousal—Thalidomide—leprosy	0.00408	0.00408	CcSEcCtD
Cidofovir—Migraine—Thalidomide—leprosy	0.00405	0.00405	CcSEcCtD
Cidofovir—Face oedema—Thalidomide—leprosy	0.00397	0.00397	CcSEcCtD
Cidofovir—Ataxia—Thalidomide—leprosy	0.00387	0.00387	CcSEcCtD
Cidofovir—Tachycardia—Dapsone—leprosy	0.00385	0.00385	CcSEcCtD
Cidofovir—Blood creatinine increased—Thalidomide—leprosy	0.00385	0.00385	CcSEcCtD
Cidofovir—Dehydration—Thalidomide—leprosy	0.00383	0.00383	CcSEcCtD
Cidofovir—Dry skin—Thalidomide—leprosy	0.00377	0.00377	CcSEcCtD
Cidofovir—Orthostatic hypotension—Thalidomide—leprosy	0.00376	0.00376	CcSEcCtD
Cidofovir—Hypokalaemia—Thalidomide—leprosy	0.00374	0.00374	CcSEcCtD
Cidofovir—Aspartate aminotransferase increased—Thalidomide—leprosy	0.0037	0.0037	CcSEcCtD
Cidofovir—Alanine aminotransferase increased—Thalidomide—leprosy	0.00363	0.00363	CcSEcCtD
Cidofovir—Muscular weakness—Thalidomide—leprosy	0.00363	0.00363	CcSEcCtD
Cidofovir—Insomnia—Dapsone—leprosy	0.00357	0.00357	CcSEcCtD
Cidofovir—Dysphagia—Thalidomide—leprosy	0.00356	0.00356	CcSEcCtD
Cidofovir—Pancreatitis—Thalidomide—leprosy	0.00349	0.00349	CcSEcCtD
Cidofovir—Bronchitis—Thalidomide—leprosy	0.00342	0.00342	CcSEcCtD
Cidofovir—Pancytopenia—Thalidomide—leprosy	0.00338	0.00338	CcSEcCtD
Cidofovir—Neutropenia—Thalidomide—leprosy	0.00332	0.00332	CcSEcCtD
Cidofovir—Pollakiuria—Thalidomide—leprosy	0.00328	0.00328	CcSEcCtD
Cidofovir—Photosensitivity reaction—Thalidomide—leprosy	0.00324	0.00324	CcSEcCtD
Cidofovir—Weight increased—Thalidomide—leprosy	0.00324	0.00324	CcSEcCtD
Cidofovir—Gastrointestinal pain—Dapsone—leprosy	0.00323	0.00323	CcSEcCtD
Cidofovir—Weight decreased—Thalidomide—leprosy	0.00322	0.00322	CcSEcCtD
Cidofovir—Hyperglycaemia—Thalidomide—leprosy	0.00321	0.00321	CcSEcCtD
Cidofovir—Pneumonia—Thalidomide—leprosy	0.00319	0.00319	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00314	0.00314	CcSEcCtD
Cidofovir—Abdominal pain—Dapsone—leprosy	0.00312	0.00312	CcSEcCtD
Cidofovir—Body temperature increased—Dapsone—leprosy	0.00312	0.00312	CcSEcCtD
Cidofovir—Renal failure—Thalidomide—leprosy	0.00312	0.00312	CcSEcCtD
Cidofovir—Neuropathy peripheral—Thalidomide—leprosy	0.00311	0.00311	CcSEcCtD
Cidofovir—Stomatitis—Thalidomide—leprosy	0.00309	0.00309	CcSEcCtD
Cidofovir—Conjunctivitis—Thalidomide—leprosy	0.00308	0.00308	CcSEcCtD
Cidofovir—Sweating—Thalidomide—leprosy	0.00304	0.00304	CcSEcCtD
Cidofovir—Haematuria—Thalidomide—leprosy	0.00302	0.00302	CcSEcCtD
Cidofovir—Epistaxis—Thalidomide—leprosy	0.00299	0.00299	CcSEcCtD
Cidofovir—Sinusitis—Thalidomide—leprosy	0.00297	0.00297	CcSEcCtD
Cidofovir—Rhinitis—Thalidomide—leprosy	0.00285	0.00285	CcSEcCtD
Cidofovir—Hepatitis—Thalidomide—leprosy	0.00285	0.00285	CcSEcCtD
Cidofovir—Pharyngitis—Thalidomide—leprosy	0.00282	0.00282	CcSEcCtD
Cidofovir—Urinary tract disorder—Thalidomide—leprosy	0.00281	0.00281	CcSEcCtD
Cidofovir—Oedema peripheral—Thalidomide—leprosy	0.0028	0.0028	CcSEcCtD
Cidofovir—Urethral disorder—Thalidomide—leprosy	0.00279	0.00279	CcSEcCtD
Cidofovir—Visual impairment—Thalidomide—leprosy	0.00274	0.00274	CcSEcCtD
Cidofovir—Erythema multiforme—Thalidomide—leprosy	0.00269	0.00269	CcSEcCtD
Cidofovir—Eye disorder—Thalidomide—leprosy	0.00266	0.00266	CcSEcCtD
Cidofovir—Tinnitus—Thalidomide—leprosy	0.00265	0.00265	CcSEcCtD
Cidofovir—Angiopathy—Thalidomide—leprosy	0.00258	0.00258	CcSEcCtD
Cidofovir—Mediastinal disorder—Thalidomide—leprosy	0.00256	0.00256	CcSEcCtD
Cidofovir—Chills—Thalidomide—leprosy	0.00255	0.00255	CcSEcCtD
Cidofovir—Alopecia—Thalidomide—leprosy	0.00251	0.00251	CcSEcCtD
Cidofovir—Vomiting—Dapsone—leprosy	0.00251	0.00251	CcSEcCtD
Cidofovir—Headache—Dapsone—leprosy	0.00247	0.00247	CcSEcCtD
Cidofovir—Flatulence—Thalidomide—leprosy	0.00244	0.00244	CcSEcCtD
Cidofovir—Tension—Thalidomide—leprosy	0.00243	0.00243	CcSEcCtD
Cidofovir—Dysgeusia—Thalidomide—leprosy	0.00243	0.00243	CcSEcCtD
Cidofovir—Nervousness—Thalidomide—leprosy	0.00241	0.00241	CcSEcCtD
Cidofovir—Back pain—Thalidomide—leprosy	0.0024	0.0024	CcSEcCtD
Cidofovir—Muscle spasms—Thalidomide—leprosy	0.00238	0.00238	CcSEcCtD
Cidofovir—Nausea—Dapsone—leprosy	0.00235	0.00235	CcSEcCtD
Cidofovir—Tremor—Thalidomide—leprosy	0.00232	0.00232	CcSEcCtD
Cidofovir—Ill-defined disorder—Thalidomide—leprosy	0.0023	0.0023	CcSEcCtD
Cidofovir—Anaemia—Thalidomide—leprosy	0.00229	0.00229	CcSEcCtD
Cidofovir—Agitation—Thalidomide—leprosy	0.00228	0.00228	CcSEcCtD
Cidofovir—Angioedema—Thalidomide—leprosy	0.00226	0.00226	CcSEcCtD
Cidofovir—Malaise—Thalidomide—leprosy	0.00223	0.00223	CcSEcCtD
Cidofovir—Vertigo—Thalidomide—leprosy	0.00223	0.00223	CcSEcCtD
Cidofovir—Syncope—Thalidomide—leprosy	0.00222	0.00222	CcSEcCtD
Cidofovir—Leukopenia—Thalidomide—leprosy	0.00222	0.00222	CcSEcCtD
Cidofovir—Loss of consciousness—Thalidomide—leprosy	0.00218	0.00218	CcSEcCtD
Cidofovir—Cough—Thalidomide—leprosy	0.00216	0.00216	CcSEcCtD
Cidofovir—Convulsion—Thalidomide—leprosy	0.00215	0.00215	CcSEcCtD
Cidofovir—Hypertension—Thalidomide—leprosy	0.00214	0.00214	CcSEcCtD
Cidofovir—Arthralgia—Thalidomide—leprosy	0.00211	0.00211	CcSEcCtD
Cidofovir—Chest pain—Thalidomide—leprosy	0.00211	0.00211	CcSEcCtD
Cidofovir—Myalgia—Thalidomide—leprosy	0.00211	0.00211	CcSEcCtD
Cidofovir—Anxiety—Thalidomide—leprosy	0.0021	0.0021	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00209	0.00209	CcSEcCtD
Cidofovir—Discomfort—Thalidomide—leprosy	0.00208	0.00208	CcSEcCtD
Cidofovir—Dry mouth—Thalidomide—leprosy	0.00206	0.00206	CcSEcCtD
Cidofovir—Confusional state—Thalidomide—leprosy	0.00204	0.00204	CcSEcCtD
Cidofovir—Oedema—Thalidomide—leprosy	0.00202	0.00202	CcSEcCtD
Cidofovir—Infection—Thalidomide—leprosy	0.00201	0.00201	CcSEcCtD
Cidofovir—Shock—Thalidomide—leprosy	0.00199	0.00199	CcSEcCtD
Cidofovir—Nervous system disorder—Thalidomide—leprosy	0.00198	0.00198	CcSEcCtD
Cidofovir—Thrombocytopenia—Thalidomide—leprosy	0.00198	0.00198	CcSEcCtD
Cidofovir—Tachycardia—Thalidomide—leprosy	0.00197	0.00197	CcSEcCtD
Cidofovir—Skin disorder—Thalidomide—leprosy	0.00196	0.00196	CcSEcCtD
Cidofovir—Hyperhidrosis—Thalidomide—leprosy	0.00195	0.00195	CcSEcCtD
Cidofovir—Anorexia—Thalidomide—leprosy	0.00193	0.00193	CcSEcCtD
Cidofovir—Hypotension—Thalidomide—leprosy	0.00189	0.00189	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Thalidomide—leprosy	0.00184	0.00184	CcSEcCtD
Cidofovir—Insomnia—Thalidomide—leprosy	0.00183	0.00183	CcSEcCtD
Cidofovir—Paraesthesia—Thalidomide—leprosy	0.00182	0.00182	CcSEcCtD
Cidofovir—Dyspnoea—Thalidomide—leprosy	0.0018	0.0018	CcSEcCtD
Cidofovir—Somnolence—Thalidomide—leprosy	0.0018	0.0018	CcSEcCtD
Cidofovir—Dyspepsia—Thalidomide—leprosy	0.00178	0.00178	CcSEcCtD
Cidofovir—Decreased appetite—Thalidomide—leprosy	0.00176	0.00176	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Thalidomide—leprosy	0.00175	0.00175	CcSEcCtD
Cidofovir—Constipation—Thalidomide—leprosy	0.00173	0.00173	CcSEcCtD
Cidofovir—Pain—Thalidomide—leprosy	0.00173	0.00173	CcSEcCtD
Cidofovir—Feeling abnormal—Thalidomide—leprosy	0.00167	0.00167	CcSEcCtD
Cidofovir—Gastrointestinal pain—Thalidomide—leprosy	0.00165	0.00165	CcSEcCtD
Cidofovir—Urticaria—Thalidomide—leprosy	0.00161	0.00161	CcSEcCtD
Cidofovir—Body temperature increased—Thalidomide—leprosy	0.0016	0.0016	CcSEcCtD
Cidofovir—Abdominal pain—Thalidomide—leprosy	0.0016	0.0016	CcSEcCtD
Cidofovir—Hypersensitivity—Thalidomide—leprosy	0.00149	0.00149	CcSEcCtD
Cidofovir—Asthenia—Thalidomide—leprosy	0.00145	0.00145	CcSEcCtD
Cidofovir—Pruritus—Thalidomide—leprosy	0.00143	0.00143	CcSEcCtD
Cidofovir—Diarrhoea—Thalidomide—leprosy	0.00138	0.00138	CcSEcCtD
Cidofovir—Dizziness—Thalidomide—leprosy	0.00134	0.00134	CcSEcCtD
Cidofovir—Vomiting—Thalidomide—leprosy	0.00129	0.00129	CcSEcCtD
Cidofovir—Rash—Thalidomide—leprosy	0.00127	0.00127	CcSEcCtD
Cidofovir—Dermatitis—Thalidomide—leprosy	0.00127	0.00127	CcSEcCtD
Cidofovir—Headache—Thalidomide—leprosy	0.00127	0.00127	CcSEcCtD
Cidofovir—Nausea—Thalidomide—leprosy	0.0012	0.0012	CcSEcCtD
